HR 5772 United States House · 117th Congress

Brycen Gray and Ben Price COVID–19 Neurological Impact Act

Summary

Brycen Gray and Ben Price COVID-19 Neurological Impact Act This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection. Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses. In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.

Bill status in committee 1 of 4 stages cleared

Introduction

Oct 2021

Committee Review

Floor Vote

President

Introduced Oct 28, 2021 Last action Oct 29, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Oct 29, 2021

Committee

Referred to the Subcommittee on Health.

lower

Oct 28, 2021

Committee

Referred to the Subcommittee on Research and Technology.

lower

Oct 28, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Oct 28, 2021

Introduced

Introduced in House

lower

1 primary · 11 co-sponsors